337529-74-5

Usage

Uses

Used in Organic Synthesis:
Methyl 2-Fluoro-4-nitrophenylacetate is used as a building block in the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of new molecules with potential therapeutic properties.
Used in Pharmaceutical Research:
Methyl 2-Fluoro-4-nitrophenylacetate is utilized as a research tool in pharmaceutical studies. Its presence in the structure of compounds can lead to interesting chemical and physical properties, which can be explored for various applications in drug development.
Used in Chemical and Biological Studies:
Due to its potential biological activities, Methyl 2-Fluoro-4-nitrophenylacetate is employed in chemical and biological research to investigate its properties and interactions with other molecules. This can contribute to a better understanding of its potential applications and mechanisms of action.

InChI:InChI=1/C9H8FNO4/c1-15-9(12)4-6-2-3-7(11(13)14)5-8(6)10/h2-3,5H,4H2,1H3

Upstream product

• 188975-47-5 dimethyl 2-(2-fluoro-4-nitrophenyl)malonate 
• 369-34-6 3,4-difluoronitrobenzene 
• 67-56-1 methanol 
• 315228-19-4 2-(2-fluoro-4-nitrophenyl)acetic acid 

Downstream Products

• 869335-30-8 (6-chloro-1-([2-(trimethylsilyl)ethoxy]methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)(2-fluoro-4-nitrophenyl)acetic acid methyl ester 
• 192650-54-7 methyl 2-(4-amino-2-fluoro-phenyl)acetate 
• 1221119-68-1 2-(2-fluoro-4-nitrophenyl)ethan-1-ol 
• 1402586-84-8 phenyl 3-fluoro-4-(2-hydroxyethyl)phenylcarbamate 
• 1402581-59-2 1-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]methyl]-3-[3-fluoro-4-(2-hydroxyethyl)phenyl]urea 
• 1402581-57-0 1-[[5-tert-butyl-2-(3-chlorophenyl)-2H-pyrazol-3-yl]methyl]-3-[3-fluoro-4-(2-hydroxyethyl)phenyl]urea 

Relevant academic research and scientific papers

BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR?) AND PHARMACEUTICAL USES THEREOF

The present invention relates to benzimidazole derivatives of formula (I) as inhibitors of retinoid-related orphan receptor gamma (RORγ) protein, pharmaceutical compositions containing the compounds, preparation methods thereof, and the use of the compoun

COMPOUNDS AND METHODS FOR INHIBITING CYP26 ENZYMES

Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.

Heterocyclic compound

The present invention relates to compound (I) or a salt thereof which has a ROR γ t inhibitory action. wherein each symbol is as defined in the specification.

SUBSTITUTED PYRAZOLYL-BASED CARBOXAMIDE AND UREA DERIVATIVES BEARING A PHENYL MOIETY SUBSTITUTED WITH AN O-CONTAINING GROUP AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (Q) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

SUBSTITUTED PHENYLAMINO-PYRIMIDINES

The invention relates to substituted phenylamino-pyrimidines, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular for the treatment of cardiovascular diseases.